Ceras Pharmaceuticals Private Limited
About Ceras Pharmaceuticals Private Limited
Data last updated:
Ceras Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 April 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2002PTC048824. Its GSTIN is 33AACCC1255G1Z6 (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors Mahadevan Jayachanthrran (Whole-Time Director) and Archana Sudarshan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.23 First Floor Jawahar Nagar 13th Cross Street Near Lakshmi Nagar Porur, Chennai, Tamil Nadu, India – 600116.
As per the financials filed for FY 2024, the company reported a revenue of ₹98.98 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹2.8 Lakh (net margin 2.8%) and EBITDA of ₹4.82 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 10% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.4 Lakh and satisfied charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.23 First Floor Jawahar Nagar 13th Cross Street Near Lakshmi Nagar Porur, Chennai, Tamil Nadu, India – 600116
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ceras Pharmaceuticals Private Limited
The main business activity of Ceras Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ceras Pharmaceuticals Private Limited FY 2025 filings available
Ceras Pharmaceuticals Private Limited reported revenue of ₹98.98 Lakh (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ceras Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 4% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ceras Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.82 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.8 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ceras Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ceras Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ceras Pharmaceuticals Private Limited
Ceras Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahadevan Jayachanthrran | Whole-Time Director | 24 Apr 2002 | 24 Years 5 Months | Current |
| Archana Sudarshan | Director | 14 Sep 2014 | 12 Years 1 Months | Current |
Peer Comparison of Ceras Pharmaceuticals Private Limited
Ceras Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meluha Biomedical Private Limited | ₹99.3 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Thane, Maharashtra, India |
| Unital Pharmaceuticals Private Limited | ₹99.18 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Chandigarh, India |
| Tirhut Pharma Private Limited | ₹99.13 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Bettiah, Bihar, India |
| Parusavedee Pharma Private Limited | ₹99.05 Lakh (FY 2025) | •••• | •••• | 41.0% | •••• | Secunderabad, Telangana, India |
| Vincor Life Sciences Private Limited | ₹99.01 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Ceras Pharmaceuticals Private Limited this company | ₹98.98 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| N.E.W.S. Pharma Private Limited | ₹98.94 Lakh (FY 2022) | •••• | •••• | -9.0% | •••• | Panchkula, Haryana, India |
| Lifezest Medicare Private Limited | ₹98.89 Lakh (FY 2023) | •••• | •••• | 160.0% | •••• | Pune, Maharashtra, India |
| Medizin Labs Private Limited | ₹98.78 Lakh (FY 2019) | •••• | •••• | 7.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Albus Pharmaceuticals Private Limited | ₹98.77 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Thrissur, Kerala, India |
| Synthesis Pharmaceutical Private Limited | ₹98.67 Lakh (FY 2024) | •••• | •••• | 34.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Ceras Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ceras Pharmaceuticals Private Limited
Ceras Pharmaceuticals Private Limited is audited by M/S.S.N.RAO & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M/S.S.N.RAO & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ceras Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ceras Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2025 | Indian Overseas Bank | ₹4.4 Lakh | Open |
| 14 Aug 2015 | Indian Overseas Bank | ₹5 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Ceras Pharmaceuticals Private Limited
Ceras Pharmaceuticals Private Limited has a workforce of 9 employees as of Oct 11, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ceras Pharmaceuticals Private Limited
Ceras Pharmaceuticals Private Limited has 6 board changes on record since 2002: 4 appointments and 2 cessations. The latest: Archana Sudarshan was appointed as Director on 14 Sep 2014.
Credit Ratings, Litigation & Regulatory Alerts for Ceras Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ceras Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ceras Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ceras Pharmaceuticals Private Limited
Ceras Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCC1255G1Z6 | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ceras Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceras Pharmaceuticals Private Limited
Ceras Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 April 2002 (24+ years old) and is registered under CIN U24231TN2002PTC048824.
Ceras Pharmaceuticals reported revenue of ₹98.98 Lakh for FY 2024 (up 4% YoY).
Ceras Pharmaceuticals has 2 current directors:
- Mahadevan Jayachanthrran - Whole-Time Director
- Archana Sudarshan - Director
Ceras Pharmaceuticals reported a net profit of ₹2.8 Lakh (net margin 2.8%) and EBITDA of ₹4.82 Lakh (EBITDA margin 4.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ceras Pharmaceuticals is 22% over three years and 10% over five years. In the latest year (FY 2024) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ceras Pharmaceuticals is 33AACCC1255G1Z6, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Ceras Pharmaceuticals is U24231TN2002PTC048824. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ceras Pharmaceuticals was incorporated on 24 April 2002, making it 24+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Ceras Pharmaceuticals by revenue are Meluha Biomedical Private Limited, Unital Pharmaceuticals Private Limited, Tirhut Pharma Private Limited, Parusavedee Pharma Private Limited, Vincor Life Sciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Archana Sudarshan was appointed as Director on 14 Sep 2014. Jayalakshmi Mahadevan ceased to be Director on 14 Sep 2014. Venkata Narasimhan ceased to be Whole-Time Director on 26 Dec 2008. Ceras Pharmaceuticals has 6 board changes on record in total.
The registered office of Ceras Pharmaceuticals is at No.23 First Floor Jawahar Nagar 13th Cross Street Near Lakshmi Nagar Porur, Chennai, Tamil Nadu, India – 600116.